Staff20192020202120222023
Personnel at the end of the year281279288309309
Staff turnover in EUR137,224137,007133,295160,223179,078
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)18.0619.8621.8521.8521.85
Dividend per share-----
Basic earnings per share-0.58-0.52-0.25-0.30-0.38
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover38.638.238.449.555.3
Operating income (EBIT)-8.0-6.7-2.0-3.2-5.1
Earnings before taxes-8.7-7.6-2.6-3.7-6.0
Annual net profit/ loss-10.5-9.7-5.0-6.6-8.3
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets31.033.139.130.425.5
Total fixed assets35.339.138.647.645.5
Total assets66.272.277.778.070.9
Liabilities
Total short-term liabilities14.912.411.321.417.5
Total long-term liabilities34.333.724.622.430.4
Total provisions4.62.82.31.20.9
Equity capital17.126.141.834.223.0
Total liabilities66.272.277.778.070.9
Management:
Adriaan Moelker
Michael Schneiders
Board:
Michael Majerus
Anna Carina Eichhorn
Florian Schnabel
Wiltrud Treffenfeldt
Christine Uekert
Stephen Catling
Shareholding in %:
Apo Asset Management GmbH 2.25
Daniel Hopp 5.60
Deka Investment GmbH 1.85
FPM Frankfurt Performance Management AG 1.52
Gabriele Sachse 2.72
Joh. Berenberg, Gossler & Co. KG (Investment Management) 1.55
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH 1.51
Martin Putsch 45.40
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 3.20
Wydler Asset Management AG 2.67
Freefloat 31.72
Address: Darmstädter Strasse 34-36, 64673 Zwingenberg
T: +49-6251-93310
F: +49-6251-933111
I: http://www.brain-biotech.de
E: public@brain-biotech.de